Doehner W, Anker SD, Butler J, Zannad F, et al. Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial. Eur Heart J 2022 Jul 5. pii: 6631286. doi: 10.1093.
PMID: 35788657